Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present AngioDynamics, Inc. (NASDAQ: ANGO).

Full DD Report for ANGO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ANGO)

AngioDynamics to Present at Two Investor Conferences in May
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May: Conference: Deutsch...
Source: Business Wire
Date: April, 10 2018 16:01
Blog Exposure - Waters Corp. to Significantly Expand its Precision Chemistry Facility in Massachusetts
Stock Monitor: AngioDynamics Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 05, 2018 / Active-Investors.com has just released a free research report on Waters Corp. (NYSE: WAT). If you want access to this report all you need to do is sign up now by clicking the following li...
Source: ACCESSWIRE IA
Date: April, 05 2018 07:20
Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Multi-Color Corporation (NASDAQ:LABL), Madrigal Pharmaceuticals, Inc. (N...
Source: GlobeNewswire
Date: April, 04 2018 08:20
AngioDynamics, Inc. 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: April, 02 2018 13:09
AngioDynamics' (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call Transcript
AngioDynamics Inc. (ANGO) Q4 2017 Earnings Conference Call March 29, 2018 08:00 AM ET Executives Jim Clemmer - President and CEO Michael Greiner - Executive Vice President and CFO Steve Trowbridge - Senior Vice President, General Counsel Analysts Cecilia Furlong - Canaccord...
Source: SeekingAlpha
Date: March, 29 2018 12:02
AngioDynamics beats by $0.06, misses on revenue
AngioDynamics (NASDAQ: ANGO ): Q3 EPS of $0.25 beats by $0.06 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: March, 29 2018 07:01
AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
Fiscal 2018 Third Quarter Highlights Net sales of $83.9 million, a decrease of 2.0% year over year Gross margin expanded 300 basis points year over year to 54.2% GAAP EPS of $0.37; Adjusted EPS of $0.25 per share Announced the launch of a wireless ultrasound devic...
Source: Business Wire
Date: March, 29 2018 07:00
AngioDynamics (ANGO) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 28 2018 13:23
AngioDynamics to Present at the Needham 17th Annual Healthcare Conference
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at ...
Source: Business Wire
Date: March, 15 2018 16:01
AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the third quarter of fiscal year 2018 before the mark...
Source: Business Wire
Date: February, 27 2018 16:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1719.8019.7719.9819.63211,581
2017-06-2016.3116.1716.409915.97189,802
2017-06-1916.0016.2816.3715.94187,884
2017-06-1615.6315.9715.9815.62308,029
2017-06-1515.6415.7315.7615.56112,788

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-178,532142,4265.9905Cover
2018-08-1632,52569,14147.0416Short
2018-08-158,13118,91542.9870Short
2018-08-1430,52233,97189.8472Short
2018-08-1316,71639,24742.5918Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ANGO.


About AngioDynamics, Inc. (NASDAQ: ANGO)

Logo for AngioDynamics, Inc. (NASDAQ: ANGO)

Not available

 

Contact Information

 

 

Current Management

  • Eamonn P. Hobbs / President, CEO
  • Joseph G. Gerardi / CFO

Current Share Structure

  • Market Cap: $723,208,543 - 05/14/2018
  • Issue and Outstanding: 36,804,506 - 04/03/2018

 


Recent Filings from (NASDAQ: ANGO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 24 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: January, 05 2018

 

 


Daily Technical Chart for (NASDAQ: ANGO)

Daily Technical Chart for (NASDAQ: ANGO)


Stay tuned for daily updates and more on (NASDAQ: ANGO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ANGO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ANGO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ANGO and does not buy, sell, or trade any shares of ANGO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/